November 18, 2009 (Orlando, Florida) — The American Heart Association (AHA) and the American College of Cardiology (ACC) have issued fast-track updates to the guidance for treatment of ST-elevation MI ...
Multivessel percutaneous coronary intervention (PCI) for patients with ST-elevation myocardial infarction (STEMI) made modest inroads over the past decade in the United States, a national registry ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. There were no significant differences for survival or ...
(UPDATED) Using optical coherence tomography (OCT) guidance to determine that a STEMI patient does not, in fact, have an occlusive lesion can significantly reduce the rate of stent implantation ...
The Times Herald on MSN
Heart and stroke care gains McKenzie Health System national honors
McKenzie Health System earned two American Heart Association awards, credited with improving cardiac and stroke care in rural ...
STEMI patients undergoing primary PCI fare better when transradial versus transfemoral access is used, an updated meta-analysis shows, confirming the findings of previous pooled analyses. Transradial ...
Please provide your email address to receive an email when new articles are posted on . Risk factors for patients with acute MI have changed modestly as treatment has improved, with mortality rates ...
Sophia Antipolis, 21 September 2010: The European Society of Cardiology (ESC) welcomes a paper published today in the Journal of the American College of Cardiology (JACC )(1) highlighting concerns ...
For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the DANAMI-3-PRIMULTI trial brought greater assurance that complete revascularization ...
When timely angioplasty is unavailable to older ST-segment elevation myocardial infarction (STEMI) patients, a modified pharmaco-invasive reperfusion strategy could be reasonable, according to the ...
About The Study: In this randomized clinical trial of 3,777 patients with ST-segment elevation myocardial infarction (STEMI; a type of heart attack), the Chinese patent medicine Tongxinluo, as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results